BioCentury
ARTICLE | Company News

Endeavor Power, Parallax Diagnostics deal

December 24, 2012 8:00 AM UTC

Infectious disease diagnostic company Parallax reverse-merged with Endeavor Power in a stock deal that values Parallax at $4.5 million. Under the deal, Parallax shareholders received 90.4 million Ende...